Therefore, receptor and post-receptor downregulation of the CASR signaling may be associated with downregulated WNT5A, in line with the previously reported WNT5A downregulation in parathyroid tumors [43]. This evidence concerns the gene WNT5A and tumor of parathyroid gland.